ACTB and coronary artery disorder: Subjects included in the Non-CAD-group had 2,830e-005 (IQR 1,970e-005–4,835e-005) copies/μl after normalisation with beta-Actin while patients with NSTEMI and STEMI presented with comparable amounts of mRNA (2,925e-005 (IQR1,468e-005–7,213e-005); 3,210e-005 (IQR 1,580e-005–5,635e-005)).